AMERICAN SHARED HOSPITAL SERVICES Current Assets
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Current Assets of $17.37 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $17.37M.
- 2026-03-31: Assets, Current $18.27M.
- 2025-12-31: Assets, Current $17.72M.
- 2025-09-30: Assets, Current $20.59M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $17.37M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $18.27M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $17.72M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $20.59M 10-Q/A · filed 2026-01-16 | |
| 2025-06-30 | $24.43M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $23.74M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $26.26M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $25.72M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $25.64M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $21.36M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $20.46M 10-K · filed 2025-04-04 | |
| 2023-09-30 | $20.37M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $20.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $19.57M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $18.72M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $16.83M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $16.84M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $15.24M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $15.09M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $13.79M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $13.45M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $11.45M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $10.85M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $10.96M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $10.82M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $10.64M 10-Q/A · filed 2020-06-11 | |
| 2019-12-31 | $10.74M 10-K · filed 2021-04-06 | |
| 2019-09-30 | $10.24M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $9.95M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $9.64M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $9.95M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $9.53M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $9.76M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $9.95M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $8.89M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $9.09M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $8.85M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $8.77M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $7.87M 10-K · filed 2018-03-28 | $8.39M 10-K · filed 2017-03-27 |
| 2016-09-30 | $7.25M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $6.53M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $6.37M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $6.01M 10-K · filed 2017-03-27 | |
| 2015-09-30 | $6.59M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $6.43M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $5.85M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $14.25M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $15.13M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $15.37M 10-Q · filed 2014-08-15 | |
| 2014-03-31 | $7.25M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $7.71M 10-K · filed 2015-04-01 | |
| 2013-09-30 | $16.95M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $16.84M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $16.27M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $6.96M 10-K · filed 2014-03-31 | $15.96M 10-K · filed 2013-03-29 |
| 2012-09-30 | $16.57M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $16.39M 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $17.25M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $17.61M 10-K · filed 2013-03-29 | |
| 2011-09-30 | $14.83M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $15.09M 10-Q/A · filed 2011-10-24 | |
| 2010-12-31 | $15.07M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |